ACACIA RESEARCH CORP reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
ACACIA RESEARCH CORP has filed 1,953 SEC EDGAR filings since 18 Aug 1995

SEC filing history

Showing 301-325 of 1,000 matching filings.

Per page
25
Current page
13
EFFECT File 333-249984

EFFECT filing

Filing date
23 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
19 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-249984

FORM S-3 AMENDMENT 1

Filing date
19 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
18 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Nov 2020
Reporting date
09 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-249984

FORM S-3 REGISTRATION STATEMENT

Filing date
09 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Sep 2020
Reporting date
04 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37721

FORM 8-K

Filing date
10 Aug 2020
Reporting date
10 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37721

FORM 8-K

Filing date
03 Aug 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37721

FORM 8-K

Filing date
20 Jul 2020
Reporting date
20 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37721

FORM 8-K

Filing date
07 Jul 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37721

CURRENT REPORT

Filing date
25 Jun 2020
Reporting date
19 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Jun 2020
Reporting date
18 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

THERAVANCE BIOPHARMA, INC.

Filing date
11 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37721

8-K filing

Filing date
10 Jun 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36754

4 filing

Filing date
09 Jun 2020
Reporting date
04 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-36754

3 filing

Filing date
09 Jun 2020
Reporting date
04 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

EVOFEM BIOSCIENCES, INC.

Filing date
09 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Jun 2020
Reporting date
04 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Jun 2020
Reporting date
04 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37721

FORM 8-K

Filing date
04 Jun 2020
Reporting date
29 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .